DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Northwest Biotherapeutics, Inc. Of Upcoming Deadline
October 15 2015 - 6:45PM
Business Wire
Rigrodsky & Long, P.A.:
- Do you, or did you, own shares of
Northwest Biotherapeutics, Inc. (NASDAQ CM:
NWBO)?
- Did you purchase your shares between
March 8, 2013 and August 20, 2015, inclusive?
- Did you lose money in your
investment?
Rigrodsky & Long, P.A. reminds shareholders of Northwest
Biotherapeutics, Inc. (“Northwest Biotherapeutics” or the
“Company”) (NASDAQ CM: NWBO) of an upcoming deadline involving a
securities fraud class action lawsuit commenced against the
Company.
A complaint was filed in the United States District Court for
the District of Maryland on behalf of all persons or entities that
purchased the common stock of Northwest Biotherapeutics between
March 8, 2013 and August 20, 2015, inclusive (the “Class Period”),
alleging violations of the Securities Exchange Act of 1934 against
the Company and certain of its officers (the “Complaint”). If you
wish to serve as lead plaintiff, you must move the Court no later
than October 26, 2015.
If you purchased shares of Northwest Biotherapeutics during the
Class Period, or purchased shares prior to the Class Period
and still hold Northwest
Biotherapeutics, and wish to discuss this action or have any
questions concerning this notice or your rights or interests,
please contact Timothy J. MacFall, Esquire or Peter Allocco of
Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120,
Wilmington, DE 19803 at (888) 969-4242; by e-mail to
info@rl-legal.com; or at:
http://rigrodskylong.com/investigations/northwest-biotherapeutics-inc-nwbo.
A lead plaintiff is a representative party acting on behalf of
other class members in directing the litigation. Any member of the
proposed class may move the court to serve as lead plaintiff
through counsel of their choice, or may choose to do nothing and
remain an absent class member.
Attorney advertising. Prior results do not guarantee a similar
outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151015006851/en/
Rigrodsky & Long, P.A.Timothy J. MacFall, EsquirePeter
Allocco888-969-4242516-683-3516Fax:
302-654-7530info@rl-legal.comhttp://www.rigrodskylong.com
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Apr 2024 to May 2024
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From May 2023 to May 2024